Expression of eosinophils, RANTES and IL-25 in the first phase of Hymenoptera venom immunotherapy

INTRODUCTION: Venom immunotherapy (VIT) can protect against severe anaphylactic reactions (SR) in 80–100% of subjects allergic to Hymenoptera venom. The mechanisms of induction of immunological tolerance produced by VIT are still little known. It has been shown that VIT modulates Treg activity, Th2...

Descripción completa

Detalles Bibliográficos
Autores principales: Pałgan, Krzysztof, Żbikowska-Götz, Magdalena, Bartuzi, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507153/
https://www.ncbi.nlm.nih.gov/pubmed/32994784
http://dx.doi.org/10.5114/ada.2019.83655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507153/
https://www.ncbi.nlm.nih.gov/pubmed/32994784
http://dx.doi.org/10.5114/ada.2019.83655

Ejemplares similares